Biofabrication, Biopharmaceutical

Biopharma’s drug quality efforts are hindered by a lack of data uniformity in the supply chain according to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), which has teamed up with Open Applications Group (OAGi) to encourage the adoption of common standards.

The partnership—announced in —will focus on a...

ASME
Biofabrication, Biomanufacturing, Biopharmaceutical, COVID-19, Supply Chain

Some of the images from the first weeks of the COVID-19 pandemic are indelible: doctors and nurses wearing garbage bags instead of gowns and reusing the same protective mask for days at a time; homemade plastic face shields replacing professional-grade models; live coverage of deliveries of personal protective equipment to hard-hit hospitals. The...